Quality of Life — Preventive Health Consultations With Young Adults With Multiple Problems
Citation(s)
Freund KS, Lous J [Potentially marginalized 20-44-years-olds in general practice. Who are they? The results of a questionnaire screening]. Ugeskr Laeger. 2002 Nov 11;164(46):5367-72. Danish.
Freund KS, Lous J The effect of preventive consultations on young adults with psychosocial problems: a randomized trial. Health Educ Res. 2012 Oct;27(5):927-45. doi: 10.1093/her/cys048. Epub 2012 Apr 2.
Hansen E, Fonager K, Freund KS, Lous J The impact of non-responders on health and lifestyle outcomes in an intervention study. BMC Res Notes. 2014 Sep 11;7:632. doi: 10.1186/1756-0500-7-632.
Lous J, Freund KS Predictors of weight loss in young adults who are over-weight or obese and have psychosocial problems: a post hoc analysis. BMC Fam Pract. 2016 Apr 11;17:43. doi: 10.1186/s12875-016-0437-8.
A Study on Preventive Health Consultations in General Practice With Young Adults With Multiple Problems; a Randomised Controlled Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
